PRAX Q1 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$683,000

Gross Profit

-$25M-3634.1% margin

Operating Income

-$38M-5577.0% margin

Net Income

-$37M-5483.9% margin

EPS (Diluted)

$-10.58

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$98M

Total Liabilities

$34M

Stockholders' Equity

$64M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$683,000	$0	—
Gross Profit	-$25M	-$53M	+52.9%
Operating Income	-$38M	-$69M	+44.7%
Net Income	-$37M	-$69M	+45.5%

Revenue Segments

License

$700,000100%